Industry News
Which genes make the best baked dinner?
A project at the South Australian Research and Development Institute (SARDI) is focusing on the qualities that make lamb tender and tasty. [ + ]
Going for funding? Get a cash parachute, says Alchemia CEO
Biotech companies in the midst of new funding rounds should build an extra cushion of cash into their requests, warns Alchemia CEO Tracie Ramsdale. [ + ]
Prima meets cancer milestones
Drug development company Prima Biomed has told the market its first year research programs into cancer immunotherapy and anti-inflammatory treatments had met or exceeded their milestones. [ + ]
Starpharma finalises US nanotech set-up
Australia's place in the futuristic world of nanotechnology has been further cemented with the set up of Dendrimer Nanotechnologies (DNT) now complete. [ + ]
Strong US sales for Genetic Solutions
Two ex-CSIRO scientists who have spent four years quietly commercialising Australian expertise in livestock DNA testing are in the midst of a US sales boom. [ + ]
Peptech earns TNF patent protection in US
Sydney-based biotech Peptech has gained United States patent protection for its tumour necrotising factor (TNF) antibodies, priming the company for its next growth phase. [ + ]
Australia must wake up to the power of light
"It's time for Australian industry to wake up to the power of light," says Sir Peter Williams, President of the UK Institute for Physics.
[ + ]Researchers welcome xenotransplantation guidelines
Australian researchers have welcomed the National Health and Medical Research Council's draft guidelines on xenotransplantation, released yesterday. [ + ]
EQiTX sets itself up for biotechnology
A Western Australian oil and metal exploration company has gathered some of the top names in Australian science as it moves towards rebirth as a biotech. [ + ]
Victoria to host synchrotron conference in 2005
Victoria has beaten a host of other nations to win the right to stage an international synchrotron conference in 2005. [ + ]
BioProspect's Japanese Qcide deal
Natural insecticide developer BioProspect has reached a second deal over rights to test its new product. [ + ]
$2m government grant for Melbourne Institute
Melbourne's St Vincent's Institute of Medical Research has attracted a $2 million Victorian government grant to boost its research facilities. [ + ]
Cone snail venom could treat chronic pain
A novel compound from the venom of a cone shell marine snail found on the Great Barrier Reef may have a use as a drug to treat chronic pain, according to scientists from the University of Melbourne and the National Ageing Research Institute. [ + ]
Lawyers suggest patent system could be used as ethics tool
Ethical concerns over issues like the use of embryonic stem cells in research could be addressed in the patent system, a new paper has argued. [ + ]
Bionomics to file international patent on genes
Gene discovery group Bionomics plans to lodge an international patent covering almost 150 gene variants related to diseases including Alzheimer's, depression, epilepsy and Parkinson's. [ + ]